First GMP Warning Letter Reflects FDA's List Of Major Concerns

FDA's first warning letter concerning dietary supplement good manufacturing practices advises Coats International Holdings to follow written procedures, improve documentation and conduct appropriate identity tests

More from Archive

More from HBW Insight